UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040038
Receipt number R000045648
Scientific Title Japanese Registry of Neuroendovascular Therapy 4
Date of disclosure of the study information 2020/04/03
Last modified on 2020/04/03 05:02:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japanese Registry of Neuroendovascular Therapy 4

Acronym

JR-NET4

Scientific Title

Japanese Registry of Neuroendovascular Therapy 4

Scientific Title:Acronym

JR-NET4

Region

Japan


Condition

Condition

Neuro-endovascular therapy

Classification by specialty

Neurology Radiology Neurosurgery
Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate results and related factors by retrospective registry of neuro-endovascular therapy in Japan

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

modified Rankin Score at 30 days after procedure

Key secondary outcomes

technical succsess
major adverse event within 30days after procedure
complication within 30days after procedure


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

treated between 2015/1/1 to 2019/12/31
treated with JSNET board certified neuro-endovascular specialist
completed 30 days follow-up

Key exclusion criteria

no limitation

Target sample size

50000


Research contact person

Name of lead principal investigator

1st name Nobuyuki
Middle name
Last name Sakai

Organization

Kobe City Medical Center General Hospital

Division name

Neurosurgery

Zip code

650-0047

Address

2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047 Japan

TEL

078-302-4321

Email

n.sakai@siren.ocn.ne.jp


Public contact

Name of contact person

1st name Chiaki
Middle name
Last name Sakai

Organization

Kobe City Medical Center General Hospital

Division name

Center for Clinical Research and Innovation

Zip code

650-0047

Address

2-2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047 Japan

TEL

078-302-4321

Homepage URL

http://www.jrnet.umin.jp/

Email

chiakimk@cronos.ocn.ne.jp


Sponsor or person

Institute

Kobe City Medical Center General Hospital

Institute

Department

Personal name



Funding Source

Organization

Japanese Society of Neuoendovascular Therapy

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe City Medical Center General Hospital

Address

2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047 Japan

Tel

078-302-4321

Email

rinken@kcho.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波大学(茨城県)、京都大学(京都府)、他


Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 03 Day


Related information

URL releasing protocol

http://www.jrnet.umin.jp/

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 12 Month 11 Day

Date of IRB

2019 Year 12 Month 18 Day

Anticipated trial start date

2020 Year 01 Month 15 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

retrospective registry of neuro-endovascular therapy in Japan, this is 4th period, already 70,000 registered


Management information

Registered date

2020 Year 04 Month 03 Day

Last modified on

2020 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045648


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name